Curis Inc (CRIS) support and resistance · rev $10.9M
Curis Inc (CRIS) is a biotechnology company listed on US.
This page maps Curis Inc (CRIS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CRIS revenue for 2024-12-31 was $10.9M. Net income was -$43.4M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CRIS currently screens at market cap $22.1M.
CRIS currently screens at market cap $22.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CRIS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CRIS quote page for the session range and the stock page for the full model.
Not investment advice.